Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.74
-0.47 (-2.12%)
At close: Jul 14, 2026, 4:00 PM EDT
21.75
+0.01 (0.05%)
Pre-market: Jul 15, 2026, 8:58 AM EDT
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,645,849
Profits / Employee
$3,171,975
Market Cap
1.60B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immunocore Holdings | 524 |
| Maravai LifeSciences Holdings | 416 |
| Vir Biotechnology | 367 |
| Maze Therapeutics | 141 |
| Absci | 140 |
| MapLight Therapeutics | 133 |
| MoonLake Immunotherapeutics | 130 |
INVA News
- 27 days ago - Innoviva’s Nortiva Bio launches to develop long-acting oral medicines - TheFly
- 27 days ago - Nortiva Bio Launches to Develop Long-Acting Oral Medicines - Business Wire
- 4 weeks ago - Innoviva announces distribution, licensing agreement with Dr. Reddy’s - TheFly
- 4 weeks ago - Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Markets - Business Wire
- 5 weeks ago - Innoviva Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Innoviva to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Innoviva management to meet with BTIG - TheFly
- 2 months ago - Innoviva management to meet with BTIG - TheFly